from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3419c/gcp

LFCtreatmentdescriptionclass of inhibitor

-0.216

Amikacinug/mL Amikacintranslation

-1.345

Cap5-10ug/mL Capreomycintranslation

-1.316

Rox10-50 ug/mL Roxithromycintranslation

-0.768

SM2-5 ug/mL Streptomycintranslation

0.077

Tet5-10 ug/mL Tetracyclinetranslation

0.790

Rif0.2-5ug/mL Rifampicintranscription

-0.010

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.406

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.953

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.276

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.330

Clofazimine10-13 ug/mL Clofaziminerespiration

0.001

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.418

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.176

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.840

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.015

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.117

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.510

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.516

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.201

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

4.095

KCN5-20 ug/mL Potassium cyaniderespiration

0.060

NaN30.2-2 mM Sodium aziderespiration

-0.122

Nigericin50 uM Nigericinrespiration

-0.210

TRC10-150 ug/mL Triclosanrespiration

-0.388

TRZ10-25 ug/mL Thioridazinerespiration

1.236

Valinomycin0.5-10 uM Valinomycinrespiration

-0.585

ZnSO42 mM ZnSO4respiration

-0.112

menadione6-10 ug/mL Menadionerespiration

-0.355

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.060

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.231

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.315

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.366

NRP_1Non-replicating persistence stage 1dosRassociated

-0.204

Amp0.2mg/mL AmpicillincellWall

-0.151

Cephalexin20-100 ug/mL CephalexincellWall

-0.144

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.691

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.358

EMB10-20 ug/mL EthambutolcellWall

-0.167

Eta12-40 ug/mL EthionamidecellWall

-0.375

INH0.2-0.4 ug/mL IsoniazidcellWall

0.152

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.620

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.708

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.419

BZA0.12 mg/mL BenzamidearomaticAmides

-0.154

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.002

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.435

H2O24 mM hydrogen peroxideDNAdamaging

-0.266

Levo10 ug/mL LevofloxacinDNAdamaging

-0.026

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.067

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.080

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.187

UVUV-irradiationDNAdamaging

0.160

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.363

Antimycin12.5-50 ug/mL Antimycin A?

-0.500

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.218

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.251

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.630

PA8240.2-2 ug/mL PA-824?

1.730

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.916

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.554

Verapamil50 uM Verapamil?

0.005

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.482

methoxatin10-20 ug/mL Methoxatin?